These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 32256206)
1. Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway. Liu X; Tu Y; Wang Y; Zhou D; Chong Y; Shi L; Liu G; Zhang X; Wu S; Li H; Gao S; Niu M; Yu R Cancer Cell Int; 2020; 20():97. PubMed ID: 32256206 [TBL] [Abstract][Full Text] [Related]
2. CRM1 inhibitor S109 suppresses cell proliferation and induces cell cycle arrest in renal cancer cells. Liu X; Chong Y; Liu H; Han Y; Niu M Korean J Physiol Pharmacol; 2016 Mar; 20(2):161-8. PubMed ID: 26937212 [TBL] [Abstract][Full Text] [Related]
3. CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways. Liu X; Chong Y; Tu Y; Liu N; Yue C; Qi Z; Liu H; Yao Y; Liu H; Gao S; Niu M; Yu R J Hematol Oncol; 2016 Oct; 9(1):108. PubMed ID: 27733172 [TBL] [Abstract][Full Text] [Related]
4. Novel reversible selective inhibitor of nuclear export shows that CRM1 is a target in colorectal cancer cells. Niu M; Chong Y; Han Y; Liu X Cancer Biol Ther; 2015; 16(7):1110-8. PubMed ID: 25996664 [TBL] [Abstract][Full Text] [Related]
5. Novel reversible selective inhibitor of CRM1 for targeted therapy in ovarian cancer. Liu X; Chong Y; Liu H; Han Y; Niu M J Ovarian Res; 2015 Jun; 8():35. PubMed ID: 26055813 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of chromosomal region maintenance 1 suppresses the migration and invasion of glioma cells via inactivation of the STAT3/MMP2 signaling pathway. Shan Q; Li S; Cao Q; Yue C; Niu M; Chen X; Shi L; Li H; Gao S; Liang J; Yu R; Liu X Korean J Physiol Pharmacol; 2020 May; 24(3):193-201. PubMed ID: 32392910 [TBL] [Abstract][Full Text] [Related]
7. Quercetin induces MGMT Wang W; Yuan X; Mu J; Zou Y; Xu L; Chen J; Zhu X; Li B; Zeng Z; Wu X; Yin Z; Wang Q Phytomedicine; 2023 Sep; 118():154933. PubMed ID: 37451151 [TBL] [Abstract][Full Text] [Related]
8. UBA1 inhibition contributes radiosensitization of glioblastoma cells Wu C; Shen Y; Shi L; Zhang J; Guo T; Zhou L; Wang W; Zhang X; Yu R; Liu X Front Pharmacol; 2023; 14():1073929. PubMed ID: 36959858 [TBL] [Abstract][Full Text] [Related]
9. MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR-induced NF-κB activation. Liu X; Yue C; Shi L; Liu G; Cao Q; Shan Q; Wang Y; Chen X; Li H; Wang J; Gao S; Niu M; Yu R J Cell Mol Med; 2020 Jul; 24(13):7550-7562. PubMed ID: 32452133 [TBL] [Abstract][Full Text] [Related]
10. Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines. Li ZY; Li QZ; Chen L; Chen BD; Wang B; Zhang XJ; Li WP Neurochem Res; 2016 Dec; 41(12):3192-3205. PubMed ID: 27632183 [TBL] [Abstract][Full Text] [Related]
12. Tubeimoside-I sensitizes temozolomide-resistant glioblastoma cells to chemotherapy by reducing MGMT expression and suppressing EGFR induced PI3K/Akt/mTOR/NF-κB-mediated signaling pathway. Tang Q; Cao H; Tong N; Liu Y; Wang W; Zou Y; Xu L; Zeng Z; Xu W; Yin Z; Ma W; Wang Q Phytomedicine; 2022 May; 99():154016. PubMed ID: 35278900 [TBL] [Abstract][Full Text] [Related]
13. Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells. Tchoghandjian A; Jennewein C; Eckhardt I; Rajalingam K; Fulda S Cell Death Dis; 2013 Mar; 4(3):e564. PubMed ID: 23538445 [TBL] [Abstract][Full Text] [Related]
14. Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways. Zhu Y; Culmsee C; Klumpp S; Krieglstein J Neuroscience; 2004; 123(4):897-906. PubMed ID: 14751283 [TBL] [Abstract][Full Text] [Related]
15. The positive regulatory loop of TCF4N/p65 promotes glioblastoma tumourigenesis and chemosensitivity. Hu Y; Zhang B; Lu P; Wang J; Chen C; Yin Y; Wan Q; Wang J; Jiao J; Fang X; Pu Z; Gong L; Ji L; Zhu L; Zhang R; Zhang J; Yang X; Wang Q; Huang Z; Zou J Clin Transl Med; 2022 Sep; 12(9):e1042. PubMed ID: 36116131 [TBL] [Abstract][Full Text] [Related]
16. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway. Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149 [TBL] [Abstract][Full Text] [Related]
17. Curcumin potentiates rhabdomyosarcoma radiosensitivity by suppressing NF-κB activity. Orr WS; Denbo JW; Saab KR; Ng CY; Wu J; Li K; Garner JM; Morton CL; Du Z; Pfeffer LM; Davidoff AM PLoS One; 2013; 8(2):e51309. PubMed ID: 23408929 [TBL] [Abstract][Full Text] [Related]
18. DNA damage-induced NF-κB activation in human glioblastoma cells promotes miR-181b expression and cell proliferation. Xu RX; Liu RY; Wu CM; Zhao YS; Li Y; Yao YQ; Xu YH Cell Physiol Biochem; 2015; 35(3):913-25. PubMed ID: 25633526 [TBL] [Abstract][Full Text] [Related]
19. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma. Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606 [TBL] [Abstract][Full Text] [Related]
20. Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβ kinase activity and interrupting NF-κB/COX-2-mediated signaling cascades. Wang X; Yu Z; Wang C; Cheng W; Tian X; Huo X; Wang Y; Sun C; Feng L; Xing J; Lan Y; Sun D; Hou Q; Zhang B; Ma X; Zhang B J Exp Clin Cancer Res; 2017 Jul; 36(1):93. PubMed ID: 28701209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]